Article 06 Jun 2024 Maryland's 2024 Legislative Session Brings Substantial New Obligations For Employers United States Employment
Article 06 Jun 2024 FCC Proposes $8 Million in Fines Against Telecom Company and Political Consultant for Using Deepfake Generative Artificial Intelligence United States Media & IT
Article 06 Jun 2024 Accelerating Privacy Scrutiny: Key Developments For The Auto Industry United States Privacy
Article 05 Jun 2024 FDA Approves First Interchangeable Biosimilar Of Alexion's Soliris® (Eculizumab) – Amgen's Bkemv™ (Eculizumab-Aeeb) United States IP
Article 05 Jun 2024 Amgen Files BPCIA Lawsuit Against Celltrion's Proposed Prolia® / Xgeva® (Denosumab) Biosimilar CT-P41 United States Healthcare
Article 05 Jun 2024 U.S. Patent And Trademark Office Rejects 'Contingent' Terminal Disclaimer United States IP
Article 04 Jun 2024 National Telecommunications And Information Administration Seeks Comments Regarding The Advancement Of 6G Technology United States Media & IT
Article 04 Jun 2024 Colorado's Landmark AI Law: Essential Insights For Businesses United States Technology
Article 31 May 2024 Fresenius Kabi Announces FDA Acceptance Of ABLA For Prolia® / Xgeva® (Denosumab) Biosimilar Candidate FKS518 United States IP